ISOPROTRACE 10mcg kit for radiopharmaceutical preparations medication leaflet

V09IX14 • gallium gozetotide (68Ga) • Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection

Gallium (68Ga) gozetotide is a radiopharmaceutical agent used in PET imaging for the detection of recurrent or metastatic prostate cancer. It binds to the prostate-specific membrane antigen (PSMA) present on cancer cells.

The medication is administered intravenously and helps accurately identify the location of cancer, providing essential information for treatment planning.

Adverse reactions may include nausea, headache, injection site reactions, or, in rare cases, allergic responses. Radiation exposure is minimal and well-controlled.

It is important to discuss your medical history with your doctor and follow all instructions before the procedure.